NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02627963,A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC),https://clinicaltrials.gov/study/NCT02627963,,COMPLETED,"This is a Phase 3, open-label, randomized, controlled, multi-national, multi-center, parallel-arm study comparing tivozanib to sorafenib in participants with refractory advanced renal cell carcinoma (RCC).

Participants will be randomized (1:1) to treatment with tivozanib or sorafenib.

Participants will be stratified by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk category (favorable; intermediate; poor) and prior therapy (two prior vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR TKI); a prior checkpoint inhibitor \[programmed cell death -1 protein (PD-1) or PD-1 ligand (PD1-L) inhibitor\] plus a prior VEGFR TKI; a prior VEGFR TKI plus any other systemic agent).

All participants will be evaluated for progression free survival, overall survival, objective response rate, and the duration of response as well as safety and tolerability.

Pharmacokinetic (PK) analyses are also included in study.",YES,"Carcinoma, Renal Cell",DRUG: Tivozanib hydrochloride|DRUG: Sorafenib,"Progression-free Survival (PFS), The PFS, as assessed by a blinded independent radiological review (IRR), is defined as the time from randomization to first documentation of objective tumor progression (progressive disease) or death due to any reasons whichever comes first. Disease progression per RECIST 1.1 criteria is defined as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions., From date of randomization until the date of first documented progression or date of death from any cause, whichever came first. Disease progression was assessed every 8 weeks (up to approximately 5 years)","Overall Survival (OS), The OS is defined as the time from the date of randomization to date of death due to any cause., Date of randomization to date of death (up to approximately 5 years)|Objective Response Rate (ORR), The ORR is defined as the percentage of participants who have at least a 30% reduction in the sum of diameters per RECIST (Version 1.1)., Every 8 weeks from date of randomization until disease progression (up to approximately 5 years)|Duration of Response (DOR), The DOR is defined as the time from the first documentation of objective tumor response to the first documentation of tumor progression per RECIST 1.1 or to death due to any cause., Assessed every 8 weeks from date of randomization until date of progression (up to approximately 5 years)",,"AVEO Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,350,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,AV-951-15-303,2016-05-24,2018-10-04,2021-06-21,2015-12-11,2020-02-20,2023-07-18,"University Of UA Cancer Center(UACC)/DH-SJHMC, Phoenix, Arizona, 85004, United States|Arizona Oncology Associates, PC - HAL, Phoenix, Arizona, 85016, United States|Arizona Oncology - Phoenix - Deer Valley Women's Center Loca, Phoenix, Arizona, 85027, United States|Arizona Oncology - Scottsdale, Scottsdale, Arizona, 85258, United States|City of Hope Comprehensive Breast Cancer Center, Duarte, California, 91010, United States|Long Beach Memorial Medical Center, Fountain Valley, California, 92708, United States|Marin Cancer Care, Greenbrae, California, 94904, United States|UCLA, Los Angeles, California, 90095, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, 20007, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Investigative Clinical Research of Indiana, Indianapolis, Indiana, 46260, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Midwest Cancer Center, Omaha, Nebraska, 68130, United States|Urology Cancer Center, PC, Omaha, Nebraska, 68130, United States|Comprehensive Cancer Center Of Nevada, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89074, United States|Comprehensive Cancer Center Of Nevada, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Center of Nevada, Las Vegas, Nevada, 89148, United States|Hackensack University Medical Center - John Theurer Cancer, Hackensack, New Jersey, 07601, United States|New York Oncology Hematology, P.C., Albany, New York, 12206, United States|New York Oncology Hematology, PC, Albany, New York, 12208, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|New York Oncology Hematology, P.C., Clifton Park, New York, 12065, United States|New York Presbyterian Hospital, New York, New York, 10021, United States|Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, 10032, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Wake Forest University Baptist Medical Center (WFUBMC), Winston-Salem, North Carolina, 27157, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Ohio Cancer Specialists, Mansfield, Ohio, 44906, United States|North Coast Cancer Care, Inc, Sandusky, Ohio, 44870, United States|Wooster Specialty and Surgery Center, Wooster, Ohio, 44691, United States|St. Luke University Health Network, Easton, Pennsylvania, 18045, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, 15232, United States|Texas Oncology - Austin Midtown, Austin, Texas, 78705, United States|Texas Oncology-Central Austin Cancer Center, Austin, Texas, 78731, United States|Texas Oncology - South Austin Cancer Center, Austin, Texas, 78745, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Texas Oncology - Fort Worth 12th Ave, Fort Worth, Texas, 76104, United States|Texas Oncology SW Fort Worth Cancer Center, Fort Worth, Texas, 76132, United States|Arizona Oncology Associates, PC - HAL, Fort Worth, Texas, 76177, United States|Comprehensive Cancer Centers of Nevada (CCCN), Fort Worth, Texas, 76177, United States|Comprehensive Cancer Centers of Nevada, Fort Worth, Texas, 76177, United States|Nebraska Cancer Specialists (NCS) - Midwest Cancer Center, Fort Worth, Texas, 76177, United States|Texas Oncology - El Paso Cancer Treatment Center, Fort Worth, Texas, 76177, United States|Texas Oncology-El Paso Cancer Treatment Center, Fort Worth, Texas, 76177, United States|Texas Oncology-Garland, Garland, Texas, 75042, United States|Baylor College of Medicine - Baylor Clinic, Houston, Texas, 77030, United States|Texas Oncology - Longview Cancer Center, Longview, Texas, 75601, United States|Texas Oncology, P.A., Plano, Texas, 75093, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|UZ Antwerpen, Edegem, Antwerpen, 2650, Belgium|Institut Jules Bordet, Bruxelles, Brussels Capital Region, 1000, Belgium|Grand Hôpital de Charleroi - Site Notre-Dame, Charleroi, Hainaut, 6000, Belgium|CHU Ambroise Paré, Mons, Hainaut, 7000, Belgium|Jessa Ziekenhuis - Campus Virga Jesse, Hasselt, Limburg, 3500, Belgium|CHU Dinant Godinne UCL Namur, Yvoir, Namur, 5530, Belgium|UZ Gent, Gent, Oost-Vlaanderen, 9000, Belgium|AZ Sint-Jan Brugge - Oostende - Campus Sint-Jan, Brugge, West-Vlaanderen, 8000, Belgium|British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, V5Z 4E6, Canada|Dr. Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|London Health Sciences Center, London, Ontario, N6A 4L6, Canada|Sunnybrook, Toronto, Ontario, M4N3M5, Canada|Masarykuv onkologicky ustav, Brno, Brno-město, 656 53, Czechia|FN Hradec Kralove, Hradec Kralove, Královéhradecký Kraj, 500 05, Czechia|Fakultni nemocnice Olomouc, Olomouc, Olomoucký Kraj, 779 00, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, 656 91, Czechia|Fakultni nemocnice v Motole, Praha 5, 150 06, Czechia|Herlev Hospital, Herlev, Capital, 2730, Denmark|Aarhus Universitetshospital, Aarhus C, Central Jutland, 8000, Denmark|Odense Universitetshospital, Odense, South Denmark, 5000, Denmark|Hopital Saint-André, Bordeaux Cedex, Gironde, 33075, France|CHRU de Tours - Hopital Bretonneau TOURS, Tours CEDEX 1, Indre-et-Loire, 37000, France|Institut de Cancerologie de la Loire, Saint-Priest-en-Jarez, Loire, 42271, France|Institut de Cancérologie de l'Ouest Site Paul Papin, Angers, Maine-et-Loire, 49000, France|Institut de cancérologie de Lorraine, Vandoeuvre Les Nancy, Meurthe-et-Moselle, 54519, France|centre Oscar Lambret, Lille, Nord-Pas-de-Calais, 59020, France|Clinique Victor Hugo, Le Mans, Pays-de-la-Loire, 72000, France|Institut Paoli-Calmettes, Marseille Cedex 09, 13273, France|Chu De Poitiers, Poitiers, 86021, France|ICO, Saint Herblain CEDEX, 44805, France|Institut Gustave Roussy, Villejuif, 94805, France|Universitätsklinikum Freiburg, Freiburg, Baden-Württemberg, 79106, Germany|Univesitaetsklinik Heidelberg, Heidelberg, Baden-Württemberg, 69120, Germany|Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden, Bayern, 92637, Germany|Johann Wolfgang Goethe Universität, Frankfurt am Main, Hessen, 60590, Germany|Evangelisches Krankenhaus Bielefeld, Bielefeld, Nordrhein-Westfalen, 33611, Germany|SZB Study Center University Hospital Bonn, Bonn, Nordrhein-Westfalen, D-53127, Germany|Uniklinik Köln Klinik und Poliklinik für Urologie, Köln, Nordrhein-Westfalen, 50937, Germany|Universitätsklinikum des Saarlandes, Homburg, Saarland, 66421, Germany|Universitätsklinikum Carl Gustav Carus, Dresden, Sachsen, 1307, Germany|Jena University Hospital, Jena, Thüringen, 7743, Germany|Universitätsklinikum Aachen, Aachen, 52074, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|Universität Tübingen, Tübingen, 72076, Germany|Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, 7624, Hungary|Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház, Miskolc, Borsod-Abaúj-Zemplén, 3526, Hungary|Békés Megyei Pándy Kálmán Kórház, Gyula, Békés, 5700, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpo, Szeged, Csongrád, 6720, Hungary|Debreceni Egyetem Klinikai Központ, Debrecen, Hajdú-Bihar, 4032, Hungary|Szent Margit Kórház, Budapest, 1032, Hungary|Magyar Honvédség Egészségügyi Központ, Budapest, 1062, Hungary|Semmelweis Egyetem, Budapest, 1082, Hungary|Semmelweis Egyetem, Budapest, 1083, Hungary|Országos Onkológiai Intézet, Budapest, 1122, Hungary|Egyesített Szent István és Szent László Kórház-Rendelőintéze, Budapest, H-1096, Hungary|Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár, 7400, Hungary|Markusovszky Egyetemi Oktatókórház, Szombathely, H-9700, Hungary|Zala Megyei Korhaz, Zalaegerszeg, H-8900, Hungary|Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo, Foggia, 71013, Italy|Irccs Irst, Meldola, Forli, 47014, Italy|Istituto Clinico Humanitas Rozzano, IRCCS, Rozzano, Milano, 20089, Italy|Usl 7 Siena - Ospedale Alta Valdelsa ASL TOSCANA SUD-EST, Poggibonsi, Siena, 53100, Italy|Istituto di Candiolo, IRCCS, Candiolo, Torino, 10060, Italy|Ospedale S.Donato, AUSL 8 di Arezzo, Arezzo, 52100, Italy|Centro di Riferimento Oncologico IRCCS, Aviano, 33081, Italy|AO Spedali Civili di Brescia, PO Spedali Civili, Brescia, 25123, Italy|P.O. Ss. Annunziata, Chieti, 66013, Italy|ASST-Istituti Ospitalieri di Cremona, AO di Cremona, Cremona, 26100, Italy|AOU Careggi, Firenze, Italy|IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca, Genova, 16132, Italy|Ospedale Vito Fazzi, ASL Lecce, Lecce, 73100, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy|Ieo, Irccs, Milano, Italy|AOU Policlinico di Modena, Modena, 41124, Italy|IRCCS Fondazione ""Giovanni Pascale"", Napoli, 80131, Italy|Istituto Oncologico Veneto IOV-IRCCS, Padova, 35128, Italy|IRCCS Policlinico San Matteo, Pavia, 27100, Italy|PU Campus Bio-medico di Roma, Roma, 00128, Italy|Regina Elena, Istituto Nazionale dei Tumori, IFO, IRCCS, Roma, 144, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, 151, Italy|Azienda Ospedaliera S. Maria di Terni, Terni, 5100, Italy|Europejskie Centrum Zdrowia Otwock, Szpital im. F. Chopina, Otwock, Mazowieckie, 05-400, Poland|Centrum Onkologii - Instytut im. Marii Sklodowskiej - Curie, Warszawa, Mazowieckie, 02-781, Poland|MAGODENT Sp. z o.o. Szpital Onkologiczno-Kardiologiczny, Warszawa, Mazowieckie, 04-125, Poland|Szpital Specjalist w Brzozowie Podkarpacki Ośrodek Onkologiczny, Brzozow, 36-200, Poland|COPERNICUS Podmiot Leczn. Sp z o.o.,Wojew. Centrum Onkologii, Gdansk, 80-219, Poland|NZOZ Vesalius Sp. z o.o., Krakow, 31-216, Poland|Uniwersytecki Szpital Kliniczny im. J. Mikulicza-Radeckiego, Wroclaw, 50-556, Poland|H.G.U. de Elche, Elche, Alicante, 03203, Spain|H.U.Son Espases, Palma, Baleares, 07010, Spain|Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Institut Catalá d´Oncología (I.C.O.), L'Hospitalet De Llobregat, Barcelona, 08907, Spain|C.S. Parc Taulí, Sabadell, Barcelona, 08208, Spain|H.U.F. Alcorcón, Alcorcón, Madrid, 28922, Spain|H.U.P Hierro-Majadahonda, Majadahonda, Madrid, 28222, Spain|C.H. de Navarra, Pamplona, Navarra, 31008, Spain|H.del Mar, Barcelona, 08003, Spain|H.Sta.Creu i St.Pau, Barcelona, 08025, Spain|H.U.Vall d'Hebrón, Barcelona, 08035, Spain|H. Clinic de Barcelona, Barcelona, 08036, Spain|H.U. Reina Sofía, Córdoba, 14004, Spain|ICO-H.U.Dr.J.Trueta, Girona, 17007, Spain|C.H. de Jaén, Jaén, 23007, Spain|H.G.U. G. Marañón, Madrid, 28007, Spain|H.U. Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|H.C. S.Carlos, Madrid, 28040, Spain|H.U. F. Jiménez Díaz, Madrid, 28040, Spain|H.U. 12 de Octubre, Madrid, 28041, Spain|H.U. La Paz, Madrid, 28046, Spain|H. Madrid Norte Sanchinarro, Madrid, 28050, Spain|H.U. Virgen de la Victoria, Málaga, 29010, Spain|H.U.V. Macarena, Sevilla, 41009, Spain|F.I. Valenciano de Oncología, Valencia, 46009, Spain|H.U.P.La Fe, Valencia, 46026, Spain|H.U. Miguel Servet, Zaragoza, 50009, Spain|Addenbrooke's Hospital, Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom|Beatson West Of Scotland Cancer Centre, Glasgow, Glasgow City, G12 0YN, United Kingdom|Cheltenham General Hospital, Cheltenham, Gloucestershire, GL53 7AN, United Kingdom|Southampton University Hospitals Nhs Trust, Southampton, Hampshire, SO16 6YD, United Kingdom|East Lancashire Hospitals NHS Trust, Blackburn, Lancashire, BB2 3HH, United Kingdom|Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, PR2 9HT, United Kingdom|Royal Stroke Center, Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom|The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, United Kingdom|St James's University Hospital / Leeds Teaching Hospitals, Leeds, LS9 7TF, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW36JJ, United Kingdom|Charing Cross Hospital, London, W6 8RF, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Mount Vernon Cancer Care, Middlesex, HA6 2RN, United Kingdom|Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, NG5 1PB, United Kingdom|Churchill Hospital [Oncology], Oxford, OX3 7LJ, United Kingdom|Singleton Hospital, Swansea, SA2 8QA, United Kingdom|New Cross Hospital, Wolverhampton, WV10 0QP, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/63/NCT02627963/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/63/NCT02627963/SAP_001.pdf"
